A study to compare two formulations of Ponesimod in healthy volunteers

• Research type

  Research Study

• Full title

  Single-center, open-label, randomized, two-way crossover study to investigate the absolute bioavailability of a single oral dose of Ponesimod in healthy male subjects

• IRAS ID

  145127

• Contact name

  Salvatore Febbraro

• Contact email

  salvatore.febbraro@simbec.co.uk

• Sponsor organisation

  Actelion Pharmaceuticals Limited

• Eudract number

  2013-002898-21

• ISRCTN Number

  To be registered

• REC name

  Wales REC 2

• REC reference

  13/WA/0369

• Date of REC Opinion

  8 Jan 2014

• REC opinion

  Further Information Favourable Opinion